Two new Covid vaccines and one antiviral drug approved in India

Two new Covid vaccines and one antiviral drug approved in India

Daily Current Affairs   /   Two new Covid vaccines and one antiviral drug approved in India

Change Language English Hindi

Category : National Published on: December 29 2021

Share on facebook
  • The use of two new Covid vaccines as well as an antiviral oral medicine has been approved by the Central Drugs Standard Control Organization.
  • The names of these two covid vaccines are CORBEVAX and COVOVAX, and the antiviral drug is Molanupiravir. Molanupiravir is recommended to be taken only in case of emergency.
  • Corbevax Vaccine is an RBD protein subunit vaccine produced in India by Biological E, a Hyderabad-based company. COVOVAX Vaccine is manufactured by Serum Institute.
  • The total number of vaccines approved for emergency use has now risen to eight.
  • Covishield, Covaxin, Sputnik V, Moderna, Johnson & Johnson, and ZyCoV-D are the only Vaccine that have received approval so far.
Recent Post's
  • Pakistan shuts airspace and halts trade with India post-Pahalgam attack.

    Read More....
  • BHIM app introduces UPI Circle feature with partial delegation.

    Read More....
  • Pakistan terms diversion of Indus waters as ‘act of war’, threatens Simla Agreement abeyance.

    Read More....
  • Tamil Nadu bans raw egg-based mayonnaise for a year due to health risks.

    Read More....
  • Sports certificates now available via DigiLocker: Launched by Union Minister Mandaviya.

    Read More....
  • World Bank revises India’s 2025-26 GDP growth forecast to 6.3%.

    Read More....
  • US imposes fresh sanctions on Iran’s energy sector amid nuclear talk uncertainty.

    Read More....
  • Klaus Schwab resigns as WEF Chairman after five decades; interim chair appointed.

    Read More....
  • UNESCO adds 16 new Global Geoparks, bringing total to 229 across 50 countries.

    Read More....
  • World Immunization Week (April 24–30) promotes vaccine awareness to protect all age groups.

    Read More....